🇺🇸 FDA
Patent

US 12083162

Universal nanosponge for treating respiratory viral infection

granted A61KA61K38/1796A61K47/6901

Quick answer

US patent 12083162 (Universal nanosponge for treating respiratory viral infection) held by The Regents of the University of California expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/1796, A61K47/6901, A61K9/127, A61K9/5176